Pages that link to "Q43157204"
Jump to navigation
Jump to search
The following pages link to Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei (Q43157204):
Displaying 50 items.
- Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase (Q24304122) (← links)
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs (Q28066801) (← links)
- Endoplasmic reticulum stress is involved in the response of human laryngeal carcinoma cells to Carboplatin but is absent in Carboplatin-resistant cells (Q28533746) (← links)
- Germline stem cell gene PIWIL2 mediates DNA repair through relaxation of chromatin (Q28593830) (← links)
- Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention (Q30447637) (← links)
- ERCC1 isoform expression and DNA repair in non-small-cell lung cancer (Q30580553) (← links)
- Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy (Q33295489) (← links)
- Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of cisplatin-induced neuropathy (Q33482074) (← links)
- Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads (Q33506479) (← links)
- Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate (Q33564338) (← links)
- Photo-cross-linking of XPC-Rad23B to cisplatin-damaged DNA reveals contacts with both strands of the DNA duplex and spans the DNA adduct (Q33612006) (← links)
- Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer (Q33788519) (← links)
- Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin (Q33994331) (← links)
- Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. (Q34214639) (← links)
- Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer (Q34479313) (← links)
- Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature (Q34562736) (← links)
- Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells (Q34722650) (← links)
- Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation. (Q35067924) (← links)
- Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model (Q35777174) (← links)
- Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts (Q36863139) (← links)
- Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer (Q36817080) (← links)
- Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device (Q36877212) (← links)
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles (Q36970889) (← links)
- Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network (Q36994777) (← links)
- DNA damage response in peripheral nervous system: coping with cancer therapy-induced DNA lesions (Q37069571) (← links)
- Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment (Q37185747) (← links)
- Monofunctional and higher-valent platinum anticancer agents. (Q37282213) (← links)
- Role of CFTR in oxidative stress and suicidal death of renal cells during cisplatin-induced nephrotoxicity. (Q37299627) (← links)
- Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts (Q37309473) (← links)
- Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution (Q37346994) (← links)
- Vasculogenic mimicry in small cell lung cancer (Q37408684) (← links)
- Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing. (Q37566689) (← links)
- Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11. (Q37682756) (← links)
- H2AX a promising biomarker for lung cancer: a review (Q38155902) (← links)
- Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer. (Q38697331) (← links)
- ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer (Q38721568) (← links)
- MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer (Q38734519) (← links)
- ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma (Q38798948) (← links)
- Cisplatin resistance in cell models: evaluation of metallomic and biological predictive biomarkers to address early therapy failure. (Q38829177) (← links)
- Caenorhabditis elegans as a powerful alternative model organism to promote research in genetic toxicology and biomedicine (Q38904492) (← links)
- Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells. (Q39540757) (← links)
- Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression (Q39655180) (← links)
- Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors (Q41276800) (← links)
- Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines (Q41667158) (← links)
- Biodistribution of cisplatin revealed by imaging mass cytometry identifies extensive collagen binding in tumor and normal tissues (Q41671334) (← links)
- Late activation of stress-activated protein kinases/c-Jun N-terminal kinases triggered by cisplatin-induced DNA damage in repair-defective cells. (Q41876225) (← links)
- Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes (Q42130904) (← links)
- In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin (Q42362653) (← links)
- Cisplatin alters the function and expression of N-type voltage-gated calcium channels in the absence of morphological damage of sensory neurons (Q47153113) (← links)
- A new strategy for metal labeling of glycan structures in antibodies. (Q47417967) (← links)